IRCT2015081723659N1已完成未知
Evaluation effects of nebulaized gentamycin in COPD-exacerbation
Vice chancellor for research, Shahrekord University of Medical Sciences0 个研究点目标入组 82 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 90 years（—）
- 性别
- All
入选标准
- •absence of renal failure; lack of sensitivity to gentamicin; no cancer; no bronchiectasis; no heart disease; grade 1, 2 and 3
- •Exclusion criteria: heart disease; kidney failure; cancer; bronchiectasis; pulmonary infection; other; sensitivity to gentamicin; Grid 4.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Can long term nebulised gentamicin reduce the bacterial burden, break the vicious cycle of inflammation and improve quality of life in patients with bronchiectasis? - Impact of nebulised gentamicin in patients with bronchiectasisBronchiectasis is respiratory disease with damaged airways. Such patients have frequent bacterial chest infections. The aim of our study is to assess whether nebulised gentamicin 80mg twice daily will reduce the bacteria in the airways and make patients feel better.EUCTR2006-000338-10-GBHS Lothian Health Board
招募中
2 期
Investigating the preventive effect of ethanol and gentamicin in central venous catheter infectioIRCT20221129056657N3Mashhad University of Medical Sciences228
已完成
不适用
Phase II study of combination chemotherapy of gemcitabine, TS-1 and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.nresectable advanced pancreatic cancerJPRN-UMIN000006161Jikei University school of Medicine30
已完成
不适用
Phase II study of combination chemotherapy of gemcitabine, TS-1 and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.nresectable advanced pancreatic cancerJPRN-UMIN000008413Jikei University School of Medicine30
进行中（未招募）
不适用
Efficacy of MM005-Granulae as prophylaxis for nocturnal hypoglycemia in insulin treated Type 1 diabetic subjects. A double-blind, randomized, placebo-controlled phase II multi-center study in three parallel arms. - GLU-005Diabetes type IMedDRA version: 6,1Level: LLTClassification code 10045228EUCTR2004-002070-36-SEMetcon Medicin AB160